Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 21;9(2):163.
doi: 10.3390/nu9020163.

Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications

Affiliations
Review

Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications

Sirichai Adisakwattana. Nutrients. .

Abstract

With recent insight into the development of dietary supplements and functional foods, search of effective phytochemical compounds and their mechanisms involved in prevention and management of diabetes and its complications are now being assessed. Cinnamic acid and its derivatives occur naturally in high levels of plant-based foods. Among various biological activities, cinnamic acid and its derivatives are associated with a beneficial influence on diabetes and its complications. The aim of the review is to summarize the potential mechanisms of these compounds for prevention and management of diabetes and its complications. Based on several in vitro studies and animal models, cinnamic acid and its derivatives act on different mechanism of actions, including stimulation of insulin secretion, improvement of pancreatic β-cell functionality, inhibition of hepatic gluconeogenesis, enhanced glucose uptake, increased insulin signaling pathway, delay of carbohydrate digestion and glucose absorption, and inhibition of protein glycation and insulin fibrillation. However, due to the limited intestinal absorption being a result of low bioavailability of cinnamic acid and its derivatives, current improvement efforts with entrapping into solid and liquid particles are highlighted. Further human clinical studies are needed to clarify the effects of cinnamic acid and its derivatives in diabetic patients.

Keywords: cinnamic acid and its derivatives; complications; diabetes; mechanisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The chemical structure of cinnamic acid and its derivatives. (A) Cinnamic acid; (B) o-Hydroxycinnamic acid; (C) m- Hydroxycinnamic acid; (D) p- Hydroxycinnamic acid; (E) o-Methoxycinnamic acid; (F) m-Methoxycinnamic acid; (G) p-Methoxycinnamic acid; (H) Ferulic acid (I) Isoferulic acid; (J) Caffeic acid.
Figure 2
Figure 2
Schematic diagram represents the mechanism actions of cinnamic acid and its derivatives for prevention and management of diabetes and its complication. (↑) Increase, (↓) Decrease.
Figure 3
Figure 3
Mechanisms of ferulic acid, caffeic acid, p-hydroxycinnamic acid, cinnamic acid, and isoferulic acid for stimulating glucose uptake in adipocytes and muscle.
Figure 4
Figure 4
Inhibition of carbohydrate digestive enzymes (pancreatic α-amylase, maltase, and sucrase) and monosaccharide absorption (GLUT2) by ferulic acid, isoferulic acid, and caffeic acid.
Figure 5
Figure 5
Graphical presentation of possible anti-glycation mechanisms of cinnamic acid and its derivatives.
Figure 6
Figure 6
The mechanism of ferulic acid and isoferulic acid on prevention of methylglyoxal-induced protein and DNA damage.

Similar articles

Cited by

References

    1. Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus—Present and future perspectives. Nat. Rev. Endocrinol. 2011;8:228–236. doi: 10.1038/nrendo.2011.183. - DOI - PubMed
    1. Pavkov M.E., Bennett P.H., Knowler W.C., Krakoff J., Sievers M.L., Nelson R.G. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA. 2006;296:421–426. doi: 10.1001/jama.296.4.421. - DOI - PubMed
    1. American Diabetes Association Standards of medical care in diabetes-2011. Diabetes Care. 2011;34:S11–S61. - PMC - PubMed
    1. Stein S.A., Lamos E.M., Davis S.N. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin. Drug. Saf. 2013;12:153–175. doi: 10.1517/14740338.2013.752813. - DOI - PMC - PubMed
    1. Scheen A.J. SGLT2 inhibition: Efficacy and safety in type 2 diabetes treatment. Expert Opin. Drug Saf. 2015;14:1879–1904. doi: 10.1517/14740338.2015.1100167. - DOI - PubMed

MeSH terms